Search results for: C. Recchia

Authors: O. Rachinel, C. Recchia, M. Bourel, B. Recchia

Abstract:

Dry microfine steam (DMS) technology, developed by Laurastar, was shown to effectively eliminate a range of pathogens such as Sars-CoV-2, E. coli, S. aureus and C. Albicans. The aim of this study was to investigate the effect of DMS technology on allergens. Therefore, the application of the DMS technology was tested on two common allergens (Dermatophagoides pteronyssinus and cat allergen Fel d 1), on different inert surfaces (e.g., cotton), during 2 to 3 seconds. Quantification of the remaining allergens was performed and the reduction rates reached 100% in 3 seconds for D. pteronyssinus and 97,74% in 2 seconds for cat allergens. In conclusion, DMS showed high efficacy in the elimination of common allergens and could be seen as a natural solution to improve domestic hygiene and reduce allergies.

Keywords: steam, allergens, dust mites, pollens

Procedia PDF Downloads 110

Authors: C. Recchia, M. Bourel, B. Recchia

Abstract:

Microorganisms (viruses, bacteria, fungi) are responsible for most communicable diseases, threatening human health. For domestic use, chemical agents are often criticized because of their potential dangerousness, and natural solutions are needed. Application of the “dry microfine steam” (DMS) technology was tested on a selection of common pathogens (SARS-CoV-2, enterovirus EV-71, human coronavirus 229E, E. coli, S. aureus, C. albicans), on different innate surfaces, for 5 to 10 seconds. Quantification of the remaining pathogens was performed, and the reduction rates ranged from 99.8% (S. aureus on plastic) to over 99.999%. DMS showed high efficacy in the elimination of common microorganisms and could be seen as a natural alternative to chemical agents to improve domestic hygiene.

Keywords: steam, SARS-CoV-2, bactericidal, virucidal, fungicidal, sterilization

Procedia PDF Downloads 137

Authors: E. Solfaroli Camillocci, C. Mancini-Terracciano, V. Bocci, A. Carollo, M. Colandrea, F. Collamati, M. Cremonesi, M. E. Ferrari, P. Ferroli, F. Ghielmetti, C. M. Grana, M. Marafini, S. Morganti, M. Patane, G. Pedroli, B. Pollo, L. Recchia, A. Russomando, M. Schiariti, M. Toppi, G. Traini, R. Faccini

Abstract:

A Radio-Guided Surgery technique exploiting β− emitting radio-tracers has been suggested to overcome the impact of the large penetration of γ radiation. The detection of electrons in low radiation background provides a clearer delineation of the margins of lesioned tissues. As a start, the clinical cases were selected between the tumors known to express receptors to a β− emitting radio-tracer: 90Y-labelled DOTATOC. The results of tests on ex-vivo specimens of meningioma brain tumor and abdominal neuroendocrine tumors are presented. Voluntary patients were enrolled according to the standard uptake value (SUV > 2 g/ml) and the expected tumor-to-non-tumor ratios (TNR∼10) estimated from PET images after administration of 68Ga-DOTATOC. All these tests validated this technique yielding a significant signal on the bulk tumor and a negligible background from the nearby healthy tissue. Even injecting as low as 1.4 MBq/kg of radiotracer, tumor remnants of 0.1 ml would be detectable. The negligible medical staff exposure was confirmed and among the biological wastes only urine had a significant activity.

Keywords: ex-vivo test, meningioma, neuroendocrine tumor, radio-guided surgery

Procedia PDF Downloads 260